HDAC9 and cancer: HDACs are overexpressed in several cancer types (8), and HDAC inhibitors can selectively alter gene transcription in part by chromatin remodeling, thus changing the structure of transcription factor complexes and resulting in cell growth arrest, reduced migration/invasion, angiogenesis, induction of apoptosis, and inhibition of DNA repair (9).